Judith Ng-Cashin,
MD
Member, Finance Committee
Chief Scientific Officer
Syneos Health
Dr. Judith Ng-Cashin is a senior physician executive with more than twenty years of experience in medicine discovery and development, portfolio strategy, marketed product support, medical governance, clinical research, bench science, and clinical medicine. Dr. Ng-Cashin currently serves as Chief Scientific Officer at Syneos Health, where she leads the integration of their therapeutic and medical and scientific expertise within clinical development and phase 1-4 trial delivery. Prior to joining Syneos Health, she was Vice President of Advisory Services in a management consultancy focused on biopharma and the health industry.
Dr. Ng-Cashin previously spent more than nine years in Research and Development at a top five pharmaceutical company. This experience spanned all phases of drug development including medical affairs and marketed product support, primarily in infectious diseases and dermatology, as well as managing the therapeutic area global portfolios, spanning early assets to marketed products, and global development strategy and franchise/portfolio strategy and prioritization.
Dr. Ng-Cashin earned her MD from Rush Medical College, and trained in Internal Medicine at the University of Chicago. She went on to sub-specialty fellowship training at the University of North Carolina in infectious diseases and hematology after which she served on the clinical faculty there. Dr. Ng-Cashin also has basic science research experience in tumor immunology and the role of chemokines and dentritic cells in tumor immunosurveillance.
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China